Table 1 Clinical characteristics of patients according to RHBDF2 expression in KIRC-TCGA
From: RHBDF2 gene functions are correlated to facilitated renal clear cell carcinoma progression
Characteristics | Total number | RHBDF2 Expression in Groups | P-value | |
|---|---|---|---|---|
Low (%) | High (%) | |||
Laterality | ||||
 Left | 249 | 117 (44.15%) | 132 (50.00%) | ns |
 Right | 280 | 148 (55.85%) | 132 (50.00%) | |
Age | ||||
 ≤ 60 | 261 | 113 (42.64%) | 148 (55.85%) |  < 0.01 |
 > 60 | 269 | 152 (57.36%) | 117 (44.19%) | |
Pathologic T | ||||
 T1–2 | 350 | 186 (67.64%) | 164 (61.89%) |  < 0.001 |
 T3–4 | 190 | 89 (32.36%) | 101 (38.11%) | |
Pathologic N | ||||
 M0 | 420 | 225 (87.89%) | 195 (80.58%) |  < 0.02 |
 M1 | 78 | 31 (12.11%) | 47 (19.42%) | |
Pathologic stage | ||||
 Stage I | 265 | 143 (54.17%) | 122 (46.39%) |  < 0.05 |
 Stage II–IV | 265 | 121 (45.83%) | 141 (53.61%) | |